VVOS Vivos Therapeutics, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$0,15
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,1352 haftanın en düşüğü
$3,4252 haftanın en yükseği
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-1.90
Gelir (TTM)
$21M
rozetleriniz
52 Haftlık Aralık
$0–$3
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$2
P/E
-0.1
ROE
-6629.2%
Net Kâr Marjı
-121.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
VVOS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.15
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-1.90
Gelir (TTM)
$21M
ROE (TTM)
-6629.2%
D/E Borç/Özsermaye (MRQ)
-4.1
52 Haftlık Aralık
$0–$3
VVOS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 27 Ekim 2023 | 1-for-25 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$17M2019-12-31 → 2025-12-31
Hisse Başına Kâr$-2.072022-12-31 → 2025-12-31
Serbest Nakit Akışı$-18M2020-12-31 → 2025-12-31
Net kar marjı-121.8%2020-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | VVOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.15Y ort. ≈-1.1 | ≈-1.1 | · | · | |
| F/S (TTM) | 0.15Y ort. ≈19.1 | ≈19.1 | · | · | |
| F/D (MRQ) | -0.65Y ort. ≈29.0 | ≈29.0 | · | · | |
| EV / EBITDA | -0.9 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.15Y ort. ≈-17.5 | ≈-17.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.15Y ort. ≈-19.8 | ≈-19.8 | · | · | |
| EV / Revenue (EV / Gelir) | 0.9 | · | · | · | |
| EV / FCF | -0.9 | · | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -0.35Y ort. ≈67.6 | ≈67.6 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | VVOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 61.9%5Y ort. ≈63.5% | ≈63.5% | · | · | |
| Faaliyet Kâr Marjı (TTM) | -107.9%5Y ort. ≈-118.1% | ≈-118.1% | · | · | |
| EBITDA Margin (FAVÖK Marjı) | -106.5%5Y ort. ≈-114.1% | ≈-114.1% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -122.6%5Y ort. ≈-112.6% | ≈-112.6% | · | · | |
| Net Kâr Marjı (TTM) | -121.8%5Y ort. ≈-112.6% | ≈-112.6% | · | · | |
| ROA (TTM) | -101.5%5Y ort. ≈-94.2% | ≈-94.2% | · | · | |
| ROE (TTM) | -6629.2%5Y ort. ≈-1570.3% | ≈-1570.3% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | VVOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -4.1 | · | · | · | |
| Cari Oran (MRQ) | 0.25Y ort. ≈1.3 | ≈1.3 | · | · | |
| Quick Ratio (Cari Oran) | 0.25Y ort. ≈1.1 | ≈1.1 | · | · | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -0.1 | · | · | · | |
| Interest Coverage (Faiz Karşılama Oranı) | -14.2 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | VVOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 16.1%5Y ort. ≈7.0% | ≈7.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 2.9%5Y ort. ≈0.30% | ≈0.30% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 5.9% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | VVOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.95Y ort. ≈0.9 | ≈0.9 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 17.35Y ort. ≈27.8 | ≈27.8 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$65.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-3.2%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $-0.31 | $-0.39 | 21.4% |
| 31 Mart 2026 | May 20, 2026 | $-0.52 | $-0.46 | -12.5% |
| 31 Aralık 2025 | $-0.58 | $-0.49 | -17.6% | |
| 30 Eylül 2025 | $-0.49 | $-0.52 | 5.8% | |
| 30 Haziran 2025 | $-0.55 | $-0.39 | -40.1% | |
| 31 Mart 2025 | $-0.45 | $-0.41 | -10.3% | |
| 31 Aralık 2024 | $-0.28 | $-0.40 | 30.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $15M | $14M | $16M | $17M | $13M | $11M | |
| Cost of Revenue | $7M | $6M | $6M | $200.0K | $400.0K | $100.0K | · | |
| Gross Profit | $11M | $9M | $8M | $10M | $13M | $10M | $9M | |
| R&D Expense | $100.0K | $100.0K | $100.0K | $200.0K | $200.0K | · | · | |
| SG&A Expense | $28M | $18M | $22M | $29M | $26M | $16M | $16M | |
| Operating Expenses | $30M | $20M | $26M | $35M | $33M | $22M | $19M | |
| Operating Income | $-20M | $-11M | $-17M | $-25M | $-20M | $-12M | $-11M | |
| Interest Expense | $1M | · | · | · | $14.0K | $96.0K | $137.9K | |
| Interest Income | · | · | · | · | $117.0K | $79.0K | $21.1K | |
| Other Non-op | $-1M | $-110.0K | $-212.0K | $-190.0K | $-9.0K | · | · | |
| Pretax Income | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | $-11M | |
| Net Income | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | $-11M | |
| EPS (Basic) | $-2.07 | $-2.22 | $-11.14 | $-25.90 | $-0.96 | · | · | |
| EPS (Diluted) | $-2.07 | $-2.22 | $-11.14 | $-25.90 | · | · | · | |
| Shares (Basic) | 10,273,881 | 5,019,886 | 1,219,381 | 920,592 | 21,233,485,000 | · | · | |
| Shares (Diluted) | 10,273,881 | 5,019,886 | 1,219,381 | 920,592 | · | · | · | |
| EBITDA | $-19M | $-11M | $-17M | $-24M | $-20M | $-12M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $2M | $4M | $24M | $18M | $469.4K | |
| Receivables | $2M | $430.0K | $202.0K | $457.0K | $1M | $1M | $871.3K | |
| Prepaid Expense | $774.0K | $783.0K | $616.0K | $1M | $2M | $673.0K | $295.0K | |
| Current Assets | $4M | $7M | $2M | $5M | $27M | $20M | $2M | |
| PP&E (Net) | $4M | $3M | $3M | $3M | $3M | $872.0K | $1M | |
| PP&E (Gross) | $7M | $6M | $6M | $5M | $4M | $2M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $2M | $1M | $801.0K | $502.5K | |
| Goodwill | $9M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $4M | $409.0K | $420.0K | $302.0K | $341.0K | $270.0K | $689.2K | |
| Total Assets | $25M | $15M | $11M | $14M | $34M | $25M | $8M | |
| Accounts Payable | $2M | $1M | $2M | $1M | $920.0K | $781.0K | $1M | |
| Accrued Liabilities | $6M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Short-term Debt | $8M | · | · | · | · | · | · | |
| Current Liabilities | $18M | $5M | $7M | $7M | $8M | $8M | $9M | |
| Capital Leases | $4M | $1M | $2M | $2M | · | · | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | · | |
| Total Liabilities | $27M | $7M | $10M | $9M | $8M | $8M | $9M | |
| Long-term Debt | $727.0K | · | · | · | $1M | $1M | $4M | |
| Total Debt | $17M | · | · | · | $1M | $1M | · | |
| Common Stock | $1.0K | · | · | · | $2.0K | $2.0K | $1.2K | |
| Paid-in Capital | $124M | $112M | $93M | $84M | $81M | $52M | $20M | |
| Retained Earnings | $-125M | $-104M | $-93M | $-79M | $-56M | $-35M | $-23M | |
| Stockholders' Equity | $-1M | $8M | $411.0K | $5M | $26M | $17M | $-3M | |
| Liabilities + Equity | $25M | $15M | $11M | $14M | $34M | $25M | $8M | |
| Shares Outstanding | 9,286,609 | 5,889,520 | 1,833,877 | 920,592 | 23,012,119 | 18,209,452 | 12,444,165 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $581.0K | $621.0K | $669.0K | $733.0K | $718.0K | $751.2K | |
| Stock-based Comp | $661.0K | $762.0K | $1M | $2M | $3M | $2M | $2M | |
| Amort. of Intangibles | $600.0K | $100.0K | $100.0K | $100.0K | $300.0K | $400.0K | $424.4K | |
| Other Non-cash | $4M | $-3M | $-90.0K | $1M | · | · | · | |
| Operating Cash Flow | $-15M | $-13M | $-12M | $-20M | $-16M | $-6M | $-5M | |
| CapEx | $2M | $568.0K | $803.0K | $924.0K | $2M | $120.0K | $175.6K | |
| Investing Cash Flow | $-8M | $-568.0K | $-853.0K | $-924.0K | $-3M | $-120.0K | $86.2K | |
| Debt Issued | $11M | · | · | · | · | · | · | |
| Net Debt Issued | $11M | · | · | · | $-25.0K | $-75.0K | · | |
| Stock Issued | $6M | $8M | $4M | · | $28M | $22M | $1M | |
| Net Stock Activity | $6M | $8M | · | · | $28M | $22M | · | |
| Financing Cash Flow | $19M | $18M | $11M | · | $24M | $24M | $4M | |
| Net Change in Cash | $-4M | $5M | $-2M | $-21M | $6M | $18M | $-785.4K | |
| Free Cash Flow | $-18M | $-13M | $-13M | $-21M | $-18M | $-6M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.4% | 60.0% | 59.9% | 62.5% | 74.7% | 79.7% | · | |
| Operating Margin | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% | -92.1% | · | |
| Net Margin | -121.4% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% | · | |
| Pretax Margin | -121.7% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% | · | |
| EBITDA Margin | -106.5% | -70.5% | -120.8% | -152.0% | -120.7% | -92.1% | · | |
| ROA | -104.7% | -85.6% | -111.1% | -100.6% | -68.8% | -73.3% | · | |
| ROE | -1368.9% | -142.6% | -5944.4% | -325.4% | -70.0% | -160.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 1.5 | 0.3 | 0.8 | 3.6 | 2.6 | · | |
| Quick Ratio | 0.2 | 1.3 | 0.3 | 0.6 | 3.4 | 2.5 | · | |
| Debt / Equity | -11.4 | · | · | · | 0.0 | 0.1 | · | |
| LT Debt / Equity | -0.3 | · | · | · | · | 0.0 | · | |
| Interest Coverage | -14.2 | · | · | · | -1455.9 | -124.5 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.2 | 1.1 | 0.7 | 0.6 | 0.8 | · | |
| Receivables Turnover | 17.3 | 47.6 | 41.9 | 19.3 | 12.8 | 11.4 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.16 | $1.35 | $0.22 | $0.21 | $1.11 | $0.93 | · | |
| Revenue / Share | $1.70 | $2.99 | $11.32 | · | · | · | · | |
| Cash Flow / Share | $-1.49 | $-2.53 | $-9.80 | · | · | · | · | |
| Cash / Share | $0.22 | $1.06 | $0.90 | $0.15 | $1.04 | $1.00 | · | |
| EPS (TTM) | $-2.07 | $-2.22 | $-11.14 | $-25.90 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.1% | 8.9% | -13.9% | -5.1% | 29.2% | · | · | |
| Revenue CAGR 3Y | 2.9% | -3.8% | 1.8% | · | · | · | · | |
| Revenue CAGR 5Y | 5.9% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | $15M | $14M | $16M | $17M | $13M | · | |
| Net Income TTM | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | · | |
| Market Cap | $19M | $25M | $23M | $231M | $1.29B | $2.69B | · | |
| Enterprise Value | $34M | · | · | · | $1.27B | $2.67B | · | |
| P/E | -1.0 | -1.9 | -1.1 | -0.4 | · | · | · | |
| P/S | 1.1 | 1.7 | 1.7 | 14.4 | 76.7 | 205.9 | · | |
| P/B | -12.7 | 3.2 | 55.5 | 48.2 | 50.7 | 159.0 | · | |
| P / Tangible Book | · | 5.4 | · | 139.7 | 57.9 | 192.5 | · | |
| P / Cash Flow | -1.2 | -2.0 | -1.9 | -11.8 | -82.3 | -473.6 | · | |
| P / FCF | -1.1 | -1.9 | -1.8 | -11.3 | -71.4 | -463.8 | · | |
| EV / EBITDA | -1.8 | · | · | · | -62.4 | -222.1 | · | |
| EV / FCF | -1.9 | · | · | · | -70.1 | -460.9 | · | |
| EV / Revenue | 1.9 | · | · | · | 75.3 | 204.6 | · | |
| Earnings Yield | -102.0% | -51.7% | -89.5% | -257.7% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $5M | $4M | $7M | $4M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $100.0K | $5M | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| Gross Profit | $3M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| SG&A Expense | $7M | $9M | $9M | $8M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $6M | $7M | |
| Operating Expenses | $8M | $10M | $9M | $9M | $7M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $7M | $7M | $8M | $8M | |
| Operating Income | $-5M | $-7M | $-6M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | |
| Interest Expense | $1M | $1M | $800.0K | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-1M | $-1M | $-635.0K | $-679.0K | $-163.0K | $-4.0K | $-69.0K | $-18.0K | $-22.0K | $-1.0K | $15.0K | $-53.0K | $-225.0K | $51.0K | $-79.0K | $-36.0K | |
| Pretax Income | $-6M | $-8M | $-7M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-2M | $-6M | $-2M | $-6M | $-5M | |
| Net Income | $-5M | $-8M | $-7M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-2M | $-6M | $-2M | $-6M | $-5M | |
| EPS (Basic) | $-0.31 | $-0.52 | $-0.58 | $-0.49 | $-0.55 | $-0.45 | $0.41 | $-0.40 | $-0.60 | $-1.63 | $-3.05 | $-1.75 | $-4.62 | $-1.72 | $-18.92 | $-6.40 | |
| EPS (Diluted) | $-0.31 | $-0.52 | $-0.58 | $-0.49 | $-0.55 | $-0.45 | $0.41 | $-0.40 | $-0.60 | $-1.63 | $-3.05 | $-1.75 | $-4.62 | $-1.72 | $-18.92 | $-6.40 | |
| Shares (Basic) | 17,681,945 | 14,634,115 | · | 10,963,590 | 9,087,202 | 8,595,288 | · | 6,615,320 | 3,228,363 | 2,308,154 | · | 1,197,258 | 1,197,258 | 990,669 | · | 849,446 | |
| Shares (Diluted) | 17,681,945 | 14,634,115 | · | 10,963,590 | 9,087,202 | 8,595,288 | · | 6,615,320 | 3,228,363 | 2,308,154 | · | 1,197,258 | 1,197,258 | 990,669 | · | 849,446 | |
| EBITDA | $-5M | $-7M | · | $-5M | $-5M | $-4M | · | $-3M | $-2M | $-4M | · | $-3M | $-5M | $-5M | · | $-5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $2M | $3M | $4M | $2M | $6M | $6M | $7M | $3M | $2M | $988.0K | $4M | $7M | $4M | $7M | |
| Receivables | $1M | $2M | $2M | $2M | $2M | $718.0K | $430.0K | $454.0K | $395.0K | $525.0K | $202.0K | $228.0K | $327.0K | $321.0K | $457.0K | $866.0K | |
| Prepaid Expense | $1M | $940.0K | $774.0K | $565.0K | $695.0K | $547.0K | $783.0K | $634.0K | $554.0K | $475.0K | $616.0K | $769.0K | $1M | $1M | $1M | $2M | |
| Current Assets | $4M | $5M | $4M | $6M | $7M | $4M | $7M | $7M | $8M | $4M | $2M | $2M | $5M | $9M | $5M | $10M | |
| PP&E (Net) | $4M | $4M | $4M | $6M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $7M | $7M | $7M | $9M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Goodwill | $9M | $9M | $9M | $8M | $8M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $4M | $4M | $4M | $2M | $2M | $358.0K | $409.0K | $383.0K | $395.0K | $408.0K | $420.0K | $433.0K | $445.0K | $458.0K | $302.0K | $312.0K | |
| Total Assets | $24M | $25M | $25M | $26M | $26M | $11M | $15M | $15M | $16M | $12M | $11M | $10M | $14M | $17M | $14M | $18M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $644.0K | |
| Accrued Liabilities | $7M | $6M | $6M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Short-term Debt | $8M | $7M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $20M | $18M | $18M | $7M | $6M | $5M | $5M | $5M | $7M | $8M | $7M | $7M | $8M | $8M | $7M | $6M | |
| Capital Leases | $3M | $4M | $4M | $3M | $3M | $932.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Liabilities | $950.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $28M | $26M | $27M | $23M | $21M | $7M | $7M | $8M | $9M | $11M | $10M | $10M | $12M | $10M | $9M | $9M | |
| Long-term Debt | $582.0K | $617.0K | $753.0K | $9M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $16M | $15M | · | $17M | $15M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | · | · | · | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Paid-in Capital | $134M | $132M | $124M | $121M | $118M | $112M | $112M | $109M | $105M | $97M | $93M | $89M | $89M | $88M | $84M | $83M | |
| Retained Earnings | $-139M | $-133M | $-125M | $-118M | $-113M | $-108M | $-104M | $-101M | $-99M | $-97M | $-93M | $-89M | $-87M | $-81M | $-79M | $-73M | |
| Stockholders' Equity | $-4M | $-1M | $-1M | $3M | $5M | $4M | $8M | $8M | $6M | $582.0K | $411.0K | $46.0K | $2M | $7M | $5M | $10M | |
| Liabilities + Equity | $24M | $25M | $25M | $26M | $26M | $11M | $15M | $15M | $16M | $12M | $11M | $10M | $14M | $17M | $14M | $18M | |
| Shares Outstanding | 14,531,617 | 13,486,006 | 9,286,609 | 8,266,877 | 7,324,807 | 5,889,520 | 5,889,520 | 4,765,300 | 3,401,488 | 2,731,270 | 1,833,877 | 1,197,258 | 29,928,786 | 29,928,786 | 920,592 | 23,012,119 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $510.0K | $454.0K | $442.0K | $384.0K | $306.0K | $177.0K | $144.0K | $146.0K | $145.0K | $146.0K | $149.0K | $149.0K | $148.0K | $175.0K | $169.0K | $176.0K | |
| Stock-based Comp | $50.0K | $151.0K | $47.0K | $55.0K | $242.0K | $317.0K | $57.0K | $142.0K | $270.0K | $293.0K | $152.0K | $189.0K | $459.0K | $306.0K | $775.0K | $350.0K | |
| Amort. of Intangibles | $200.0K | $200.0K | $300.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | |
| Other Non-cash | · | · | · | · | · | $-426.0K | · | · | · | $808.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-4M | $-4M | $-3M | $-4M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-6M | |
| CapEx | $416.0K | $18.0K | $2M | $-83.0K | $771.0K | $122.0K | $165.0K | $192.0K | $60.0K | $151.0K | $165.0K | $154.0K | $245.0K | $239.0K | $200.0K | $100.0K | |
| Investing Cash Flow | $-416.0K | $-18.0K | $-2M | $83.0K | $-6M | $-122.0K | $-165.0K | $-192.0K | $-60.0K | $-151.0K | $-165.0K | $-154.0K | $-245.0K | $-289.0K | $-200.0K | $-100.0K | |
| Debt Issued | $2M | $1M | $1M | $-417.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $291.0K | $342.0K | $3M | $2M | · | · | $4M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $342.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $6M | $4M | $3M | · | · | $3M | $4M | $7M | $4M | $4M | $0 | $0 | $7M | · | · | |
| Net Change in Cash | $-336.0K | $81.0K | $-1M | $-1M | $2M | $-4M | $-51.0K | $-592.0K | $4M | $968.0K | $655.0K | $-3M | $-3M | $4M | $-3M | $-6M | |
| Free Cash Flow | · | $-6M | · | · | · | $-4M | · | · | · | $-3M | · | · | · | $-4M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.3% | 59.5% | · | 58.0% | 55.2% | 50.0% | · | 60.5% | 65.4% | 56.6% | · | 57.5% | 61.8% | 60.6% | · | 58.8% | |
| Operating Margin | -93.6% | -128.7% | · | -69.8% | -127.4% | -129.9% | · | -68.5% | -47.8% | -110.7% | · | -105.7% | -133.1% | -129.8% | · | -127.3% | |
| Net Margin | -106.4% | -149.4% | · | -79.6% | -131.2% | -128.1% | · | -67.8% | -47.6% | -110.1% | · | -63.4% | -162.8% | -44.1% | · | -128.0% | |
| Pretax Margin | -107.2% | -150.8% | · | -79.6% | -131.2% | -128.1% | · | -67.8% | -47.6% | -110.1% | · | · | · | · | · | -128.0% | |
| EBITDA Margin | -93.6% | -128.7% | · | -69.8% | -127.4% | -124.0% | · | -68.5% | -47.8% | -106.4% | · | -105.7% | -133.1% | -125.2% | · | -127.3% | |
| ROA | -21.9% | -42.3% | · | -26.4% | -23.9% | -33.5% | · | -20.4% | -13.0% | -26.0% | · | -14.6% | -29.0% | -7.3% | · | -18.3% | |
| ROE | -1427.3% | -470.0% | · | -105.9% | -91.7% | -154.9% | · | -67.8% | -45.7% | -99.4% | · | -42.3% | -65.2% | -12.2% | · | -25.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 0.3 | · | 0.8 | 1.0 | 0.8 | · | 1.4 | 1.2 | 0.4 | · | 0.3 | 0.6 | 1.1 | · | 1.6 | |
| Quick Ratio | 0.2 | 0.2 | · | 0.7 | 0.9 | 0.7 | · | 1.3 | 1.1 | 0.4 | · | 0.2 | 0.5 | 0.9 | · | 1.3 | |
| Debt / Equity | -4.1 | -13.0 | · | 6.6 | 3.4 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -0.1 | -0.4 | · | 3.3 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -4.4 | -6.0 | · | -9.5 | · | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | |
| Receivables Turnover | 3.4 | 4.1 | · | 5.2 | 3.8 | 4.9 | · | 11.3 | 11.2 | 8.1 | · | 6.0 | 6.1 | 5.8 | · | 1.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.26 | $-0.08 | · | $0.31 | $0.63 | $0.75 | · | $1.61 | $1.87 | $0.21 | · | $0.04 | $0.07 | $0.23 | · | $0.43 | |
| Revenue / Share | $0.29 | $0.35 | · | $0.62 | $0.42 | $0.35 | · | $0.58 | $1.26 | $1.48 | · | $2.76 | $0.11 | · | · | · | |
| Cash Flow / Share | · | $-0.41 | · | · | · | $-0.44 | · | · | · | $-1.09 | · | · | · | · | · | · | |
| Cash / Share | $0.12 | $0.16 | · | $0.37 | $0.60 | $0.40 | · | $1.32 | $2.03 | $0.96 | · | $0.83 | $0.13 | $0.24 | · | $0.29 | |
| EPS (TTM) | $-1.90 | $-2.14 | · | $-1.08 | $-0.99 | $-1.04 | · | $-5.68 | $-7.03 | $-11.05 | · | $-27.01 | $-31.66 | $-27.37 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21M | $20M | · | $17M | $14M | $15M | · | $15M | $14M | $13M | · | $15M | $15M | $16M | · | $16M | |
| Net Income TTM | $-25M | $-25M | · | $-17M | $-14M | $-11M | · | $-13M | $-12M | $-16M | · | $-15M | $-19M | $-20M | · | $-25M | |
| Market Cap | $7M | $16M | · | $26M | $23M | $17M | · | $12M | $8M | $13M | · | $6M | $382M | $255M | · | $374M | |
| Enterprise Value | $21M | $29M | · | $39M | $34M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.2 | -0.6 | · | -2.9 | -3.2 | -2.7 | · | -0.5 | -0.3 | -0.4 | · | -0.2 | -0.4 | -0.3 | · | · | |
| P/S | 0.3 | 0.8 | · | 1.5 | 1.6 | 1.1 | · | 0.9 | 0.5 | 1.0 | · | 0.4 | 24.7 | 15.7 | · | 22.7 | |
| P/B | -1.7 | -14.0 | · | 10.1 | 5.1 | 3.8 | · | 1.6 | 1.2 | 22.7 | · | 124.9 | 181.2 | 36.5 | · | 37.9 | |
| P / Tangible Book | · | · | · | · | · | 13.9 | · | 2.8 | 2.4 | · | · | · | · | 69.1 | · | 55.8 | |
| P / Cash Flow | · | -2.6 | · | · | · | -4.4 | · | · | · | -5.2 | · | · | · | -72.1 | · | · | |
| EV / Revenue | 1.0 | 1.5 | · | 2.3 | 2.4 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -417.6% | -181.4% | · | -34.8% | -31.3% | -36.5% | · | -217.6% | -316.7% | -228.8% | · | -562.7% | -248.3% | -321.1% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $17M | $15M | $14M | $16M | $17M |
| Brüt Kâr Marjı % | 60.4% | 60.0% | 59.9% | 62.5% | 74.7% |
| Faaliyet Kâr Marjı % | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% |
| Net Gelir | $-21M | $-11M | $-14M | $-24M | $-20M |
| Seyreltilmiş Hisse Başı Kâr | $-2.07 | $-2.22 | $-11.14 | $-25.90 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -11.4 | · | · | · | 0.0 |
| Cari Oran | 0.2 | 1.5 | 0.3 | 0.8 | 3.6 |
| Cari Oran | 0.2 | 1.3 | 0.3 | 0.6 | 3.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-18M | $-13M | $-13M | $-21M | $-18M |
Kurumsal Sahipler (13F) 24 dosya · $1.0M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
24
Tutulan Değer
$1.0M
Yeni pozisyonlar
2
Çıkan pozisyonlar
4
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 2 (-6 önceki Ç'ye göre) | 4 (+3 önceki Ç'ye göre) | 3 (0 önceki Ç'ye göre) | 4 (+2 önceki Ç'ye göre) | -1.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $617.447 | 304.161 | 61,74% | Hisse senetleri |
| Cutter & CO Brokerage, Inc. | $139.935 | 49.100 | 13,99% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $38.632 | 85.001 | 3,86% | Hisse senetleri |
| IHT Wealth Management, LLC | $34.877 | 76.736 | 3,49% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.586 | 60.629 | 2,76% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $19.320 | 42.500 | 1,93% | Hisse senetleri |
| B. Riley Wealth Advisors, Inc. | $18.767 | 38.066 | 1,88% | Hisse senetleri |
| UBS Group AG | $17.815 | 39.154 | 1,78% | Hisse senetleri |
| Centurion Wealth Management LLC | $16.219 | 35.684 | 1,62% | Hisse senetleri |
| BlackRock, Inc. | $12.643 | 27.817 | 1,26% | Hisse senetleri |
| STATE STREET CORP | $11.327 | 24.922 | 1,13% | Hisse senetleri |
| Sequoia Financial Advisors, LLC | $10.908 | 24.000 | 1,09% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $10.662 | 23.432 | 1,07% | Hisse senetleri |
| NORTHERN TRUST CORP | $9.442 | 20.775 | 0,94% | Hisse senetleri |
| Acorn Wealth Advisors, LLC | $6.716 | 14.776 | 0,67% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.579 | 10.075 | 0,46% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $2.368 | 5.211 | 0,24% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $516 | 1.143 | 0,05% | Hisse senetleri |
| SIGNATUREFD, LLC | $249 | 547 | 0,02% | Hisse senetleri |
| Blue Trust, Inc. | $73 | 160 | 0,01% | Hisse senetleri |
| Kozak & Associates, Inc. | $24 | 49 | 0,00% | Hisse senetleri |
| Global Retirement Partners, LLC | $10 | 23 | 0,00% | Hisse senetleri |
| MORGAN STANLEY | $3 | 7 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 4 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| V-CO Investors LLC, V-Co Investors 2 LLC, V-Co Investors 3 LLC, V-Co Investors 4 LLC, SP Manager LLC, Michael C. Skaff ×3 başvurular | 15 Temmuz 2026 | 19,90% | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 10 içeriden öğrenenler · 3 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Ronald Kirk Huntsman | Chief Executive Officer | 30 Haziran 2026 J | 85.910 | 0 | 0 | $0 |
| Bradford K. Amman | Principal Accounting Officer | 31 Temmuz 2026 A | 250.080 | 0 | 0 | $0 |
| Gurdev Dave Singh | Chief Medical Officer | 05 Ağustos 2021 A | · | 0 | 0 | $0 |
| Gregg C Johnson | Yönetim kurulu üyesi | 14 Eylül 2026 A | · | 0 | 0 | $0 |
| Leonard J Sokolow | Yönetim kurulu üyesi | 14 Eylül 2026 A | · | 0 | 0 | $0 |
| Ralph Elias Green | Yönetim kurulu üyesi | 20 Haziran 2024 A | · | 0 | 0 | $0 |
| Mark F. Lindsay | Yönetim kurulu üyesi | 20 Haziran 2024 A | · | 0 | 0 | $0 |
| Matthew Thompson | Yönetim kurulu üyesi | 20 Haziran 2024 A | · | 0 | 0 | $0 |
| Anja B Krammer | Yönetim kurulu üyesi | 20 Haziran 2024 A | · | 0 | 0 | $0 |
| Michael C. Skaff | 10% sahip | 30 Haziran 2026 P | · | 3 | 0 | $3.189.222 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 60.629 SH | 19 Ağustos 2026 | Günlük |
VVOS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$2.50
+1546,9%
2 22,2%
Güçlü Al
5 55,6%
Al
2 22,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-03Ortalama hedef $2.12 +1294,4%
← Tüm hedeflerin altında
Mevcut fiyat $0.15
Düşük$0.75
Ortalama$2.12
Yüksek$3.10
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| VVOS | $19M | -1.0 | 16.1% | -121.4% | -1368.9% | 60.4% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026